Impact of Obesity on Clinical, Physiologic, and Durability Outcomes After Antireflux Surgery in a 2388-patient Cohort Authors: Shahin Ayazi, Sven Eriksson, Ping Zheng, Vineeth Sadda, Michelle Bojalad, Ahmed Aly, David L. Bartlett Published: 2026 ABSTRACT Objectives:To evaluate the effect of obesity on subjective and objective outcomes after antireflux surgery (ARS).Summary of Background Data:Obesity has traditionally been viewed as a relative contraindication to ARS with some guidelines favoring Roux-en-Y gastric bypass in this population. The concern that increased intra-abdominal pressure may compromise durability is physiologically plausible, but supporting clinical evidence is limited.Methods:Consecutive patients undergoing primary fundoplication or magnetic sphincter augmentation (MSA) between 2011 and 2024 were analyzed. Patients were stratified by body mass index (BMI) <35 kg/m² or ≥35 kg/m² (obese). Preoperative characteristics and postoperative outcomes were compared, including symptom control, objective reflux parameters, and anatomic integrity.Results:A total of 2388 patients were included, of whom 309 (12.9%) had BMI ≥35. Obese patients had larger hiatal hernias (P<0.001) and higher DeMeester scores [48.7 (34.8) vs. 44.1 (35.0), P=0.030]. At 1 year after surgery, GERD-HRQL scores improved in both groups and were comparable [10.7 (12.8) vs. 10.1 (13.0)], as were patient satisfaction (81.6% vs. 83.3%) and PPI independence (85.1% vs. 85.5%) (all P>0.05). These findings remained similar at 3 years. Five-year anatomic integrity (75.8% vs. 78.2%) and revisional surgery rates (4.5% vs. 5.3%) were similar between groups (all P>0.05). However, obese patients undergoing MSA had lower rates of pH normalization (48.1% vs. 71.0%, P=0.001).Conclusion:Patients with BMI ≥35 presented with more advanced reflux but achieved comparable symptom improvement, satisfaction, and PPI independence after ARS. Anatomic integrity and revision rates were similar, with reduced pH normalization observed only in the MSA subgroup. These findings support ARS in obese patients and suggest BMI alone should not determine surgical candidacy. Obesity is a well-established risk factor for gastroesophageal reflux disease and is common among patients undergoing antireflux surgery (ARS).1 The physiologic effects of obesity, including increased intra-abdominal pressure and impairment of esophagogastric junction barrier competence, may affect surgical outcomes.2,3 However, whether obesity independently influences clinical outcomes, objective reflux control, or long-term durability after contemporary ARS remains unclear.4–6 Early surgical series demonstrated higher recurrence rates in obese patients and suggested potential differences in long-term outcomes after ARS.7,8 Subsequent studies have reported inconsistent findings, with some demonstrating comparable symptomatic and anatomic outcomes across BMI strata.9 However, these findings are difficult to interpret given heterogeneity in patient selection, definitions of failure, duration of follow-up, and use of objective postoperative testing.10–12 Systematic reviews have similarly highlighted variability in reported outcomes and follow-up.5,13,14 Most prior studies have compared nonobese and class I obesity patients (BMI 30–34.9 kg/m²), with limited data regarding class II obesity (BMI 35–39.9 kg/m²).4,6,7 Recent studies have suggested the feasibility and safety of ARS in this population, but these findings are based on limited and heterogeneous data.15–18 Consequently, consensus statements continue to acknowledge uncertainty regarding the relationship between obesity and surgical durability.19,20 The relationship between obesity and outcomes after ARS remains incompletely defined, especially in patients with class II obesity. We designed this study to evaluate subjective outcomes, objective reflux control, and durability in this population using standardized definitions and structured follow-up. These outcomes were examined across primary fundoplication and magnetic sphincter augmentation (MSA), enabling procedure-specific comparisons in patients with BMI ≥35 kg/m². METHODS Study Population This was a retrospective review of prospectively collected data from consecutive patients who underwent primary ARS at Allegheny Health Network hospitals (Pittsburgh, PA) between 2011 and 2024. Adult patients (≥18 years) undergoing primary laparoscopic fundoplication or MSA with preoperative GERD Health-Related Quality of Life (GERD-HRQL) assessment and esophageal pH monitoring were included. Patients were required to have at least 1 year of postoperative follow-up with repeat GERD-HRQL assessment and evaluation of anatomic integrity by endoscopy. The study was approved by the Institutional Review Board of Allegheny Health Network. Clinical Assessment Patients underwent standardized preoperative and postoperative evaluation, including upper endoscopy, videoesophagram, esophageal pH monitoring, high-resolution manometry, and the GERD-HRQL questionnaire. Clinically significant dysphagia and bloating were defined as scores ≥4 on the dysphagia- and bloating-related questions, respectively. Endoscopic Evaluation Endoscopy was performed by experienced endoscopists to assess key anatomic features, including the crural impression, esophagogastric junction (EGJ) position, and the presence of esophagitis graded according to the Los Angeles classification. The integrity of the surgical repair was evaluated in both forward and retroflex views. Anatomic integrity was defined as tight adherence of the valve to the endoscope throughout respiration with an appropriate configuration around the scope on retroflexion. A recurrent hernia was defined as the EGJ positioned above the crural impression on a forward view. Anatomic failure was defined as endoscopic evidence of recurrent hiatal hernia or disruption or slippage of the fundoplication or MSA device. pH Monitoring Patients were instructed to stop antisecretory medication 10 days before this examination. A Bravo esophageal pH monitoring probe (Medtronic Inc., Minneapolis, MN) was placed endoscopically 6 cm above the gastroesophageal junction. Esophageal acid exposure was recorded continuously for 48 hours. DeMeester scores >14.7 were considered abnormal. Surgical Decision-making and Surgical Procedure Patients found to have objective evidence of reflux on preoperative evaluation were offered ARS, and shared decision-making was implemented to determine the final treatment plan. High-resolution manometry was routinely incorporated into the preoperative foregut evaluation to identify significant esophageal motility disorders that could preclude ARS, including achalasia, and to guide procedure selection. Esophageal body manometric characteristics, including contractile vigor, also informed procedure selection, as patients considered for MSA were generally required to demonstrate more robust esophageal body contractility to overcome the augmented outflow resistance imposed by the device. Fundoplication was completed laparoscopically with or without robotic assistance in all patients. The surgical technique involved: takedown of the gastrohepatic ligament, adequate intra-abdominal and mediastinal esophageal mobilization to restore intra-abdominal esophageal length (≥3 cm), division of short and posterior gastric vessels for gastric mobilization, posterior hiatal closure with interrupted nonabsorbable suture, preservation of vagal nerves as technically feasible, and creation of fundoplication. The LINX device (Ethicon, Johnson & Johnson, Shoreview, MN) consists of a series of magnetic titanium beads interlinked with independent titanium wires to form a flexible and expandable ring. MSA was performed laparoscopically with mediastinal esophageal mobilization and restoration of intra-abdominal esophageal length (≥3 cm), posterior crural closure, and device placement at the level of the EGJ with the posterior vagus nerve trunk located on the outside of the magnetic ring. Device size was selected using a sizing protocol recommended by the device manufacturer. Revisional surgery in patients with anatomic failure was based on several factors, with patient symptom burden playing an important role in the decision-making process in addition to physiologic findings and objective postoperative imaging or endoscopic findings. For patients undergoing MSA, revisional surgery for the purposes of this study included device replacement, explant, or conversion to fundoplication due to recurrent reflux or anatomic failure. Device removal for dysphagia alone was not included as a revisional failure endpoint in this analysis. Statistical Analysis Patients were stratified by BMI into <35 kg/m² and ≥35 kg/m² groups. Demographics, preoperative characteristics, and postoperative outcomes were compared between groups. Subjective outcomes were assessed at 1 and 3 years postoperatively, distal esophageal acid exposure at 1 year postoperatively, and anatomic failure and revisional surgery at 1 year and longitudinally up to 5 years postoperatively. By study design, all included patients completed at least 1-year clinical follow-up, including symptom assessment and postoperative evaluation of anatomic integrity. One-year postoperative pH monitoring was available in 45.8% of patients (1093/2388) and was used for analysis of distal esophageal acid exposure. Follow-up data were available for 78.3% of patients (1870/2388) at 3 years and 69.6% (1662/2388) at 5 years. Continuous variables are presented as mean with standard deviation (SD), and categorical variables as frequency and percentage. Comparisons between groups were performed using the χ2 or Fisher exact test for categorical variables and the Mann-Whitney U or Kruskal-Wallis test for continuous variables, as appropriate. Multivariable analyses for postoperative subjective outcomes by BMI group were performed using generalized linear regression models adjusting for age, sex, preoperative grade C/D esophagitis, presence of large hiatal or paraesophageal hernia, and baseline DeMeester score. These adjustments accounted for baseline differences in demographics and disease severity between groups. Multivariable penalized Cox proportional hazards models accounting for censoring were used to estimate time to anatomic failure and time to revision across BMI groups at 5 years, adjusting for age, sex, grade C/D esophagitis, large hiatal or paraesophageal hernia, and DeMeester score. A cut-point analysis was performed to identify the BMI threshold associated with the greatest odds of postoperative pH normalization for MSA and fundoplication separately. BMI values between 30 and 39 kg/m² were evaluated in 1-unit increments, and the cut-point corresponding to the largest odds ratio (OR) was identified. Univariate logistic regression was used to model postoperative pH normalization across BMI values from 30.0 to 39.9 kg/m². Predicted probabilities with 95% CIs were plotted by BMI using linear interpolation. Statistical significance was established for two-sided P values <0.05. All analyses were performed using SAS software (version 9.4; SAS Institute Inc., Cary, NC). RESULTS The final study population consisted of 2388 patients who underwent primary ARS, including 1641 (68.7%) fundoplication procedures (84.3% Nissen; 15.7% partial) and 747 (31.3%) MSA procedures. Mean follow-up for the cohort was 3.1 (0.9) years and was comparable between BMI groups (P=0.926). A total of 309 patients (12.9%) had BMI ≥35 kg/m². Baseline characteristics stratified by BMI group are shown in Table 1. Patients with BMI ≥35 kg/m² presented with more advanced disease, including higher mean GERD-HRQL total scores [37.0 (19.1) vs. 32.2 (20.0), P=0.001], greater prevalence of large hiatal hernia (56.9% vs. 44.9%, P<0.001) and grade C/D esophagitis (15.2% vs. 11.0%, P=0.032), and higher DeMeester scores [48.7 (34.8) vs. 44.1 (35.0), P=0.030]. TABLE 1Demographics and Preoperative Clinical Characteristics Stratified by BMI (kg/m2)CharacteristicBMI <35 (n=2079)BMI ≥35 (n=309) P Age, years, mean (SD)58.8 (14.3)56.0 (13.7)<0.001Sex, n (%) Male668 (32.1)62 (20.1)<0.001 Female1411 (67.9)247 (79.9)BMI (kg/m²), mean (SD)28.0 (3.9)37.8 (3.0)<0.001GERD-HRQL scores, mean (SD) Total score32.2 (20.0)37.0 (19.1)0.001 Heartburn score13.7 (9.0)15.3 (8.5)0.015 Regurgitation score12.0 (9.1)14.0 (9.0)0.003Dysphagia, n (%)285 (18.3)52 (24.6)0.029Bloating, n (%)476 (31.7)83 (41.5)0.006Hiatal hernia, n (%)1755 (86.5)271 (90.6)0.049Large hiatal hernia (≥3 cm) or PEH, n (%)910 (44.9)170 (56.9)<0.001Esophagitis, n (%)800 (39.3)130 (43.0)0.216Grade C or D esophagitis, n (%)224 (11.0)46 (15.2)0.032DeMeester score, mean (SD)44.1 (35.0)48.7 (34.8)0.030 Demographics and Preoperative Clinical Characteristics Stratified by BMI (kg/m2) Impact of Obesity on One- and Three-year Symptomatic Outcomes Subjective outcomes at 1 and 3 years are shown in Table 2. GERD-HRQL scores improved substantially after surgery and remained durable at 3 years, with no differences between patients with BMI <35 and ≥35 kg/m² at either time point (all P>0.05). TABLE 2Subjective Outcomes Stratified by BMI (kg/m2) and Surgical Procedure at One and Three Years PostoperativelyTotal PopulationFundoplicationMagnetic Sphincter AugmentationOutcome, Mean (SD)BMI <35 (n=2079)BMI ≥35 (n=309) P BMI <35 (n=1413)BMI ≥35 (n=228) P BMI <35 (n=666)BMI ≥35 (n=81) P One year Patient satisfaction, %83.381.60.48682.682.40.92785.078.90.230 Freedom from PPI, %85.585.10.86884.183.40.80888.490.20.680 GERD-HRQL total score10.1 (13.0)10.7 (12.8)0.41210.3 (13.3)10.4 (12.7)0.5049.8 (12.5)11.1 (13.1)0.638 Heartburn score3.2 (5.9)3.2 (5.3)0.4163.3 (6.0)3.1 (5.2)0.6683.2 (5.7)3.5 (5.7)0.385 Regurgitation score2.7 (5.5)3.1 (5.7)0.2132.7 (5.7)2.8 (5.6)0.5802.8 (5.1)3.9 (6.0)0.087 Dysphagia, %7.24.20.1177.64.50.1906.63.40.354 Bloating, %20.022.20.49923.925.20.74214.115.50.764Three year Patient satisfaction, %80.883.00.69777.179.40.75986.389.50.696 Freedom from PPI, %77.776.50.84374.373.50.91983.682.40.900 GERD-HRQL total score11.1 (13.3)14.0 (17.8)0.23312.8 (13.8)12.9 (17.2)0.9389.6 (12.6)15.3 (19.0)0.108 Heartburn score3.7 (5.7)4.7 (7.2)0.5774.2 (5.9)4.4 (6.9)0.8163.3 (5.6)5.2 (7.8)0.333 Regurgitation score3.4 (6.0)4.3 (7.7)0.8654.1 (6.7)3.1 (7.3)0.1292.8 (5.3)5.8 (8.2)0.053 Dysphagia, %6.014.30.0446.121.70.0105.95.30.917 Bloating, %16.211.90.46622.113.00.31911.210.50.932 Subjective Outcomes Stratified by BMI (kg/m2) and Surgical Procedure at One and Three Years Postoperatively Symptom control, including heartburn, regurgitation, and bloating, as well as freedom from PPI therapy and patient satisfaction, was similar between BMI groups at both time points (all P>0.05). Dysphagia was more frequently reported in patients with BMI ≥35 kg/m² at 3 years on unadjusted analysis (P=0.044), but this difference was not significant after multivariable adjustment. Findings were consistent across fundoplication and MSA and remained unchanged after multivariable adjustment for demographics and baseline differences in disease severity. (Supplemental Table 1, Supplemental Digital Content 1, http://links.lww.com/SLA/F847). Impact of Obesity on Objective Reflux Control and Acid Exposure In the overall cohort, patients with BMI ≥35 kg/m² had higher postoperative DeMeester scores [20.5 (30.9) vs. 13.7 (22.2), P=0.012] and lower rates of distal esophageal acid normalization (63.7% vs. 73.5%, P=0.022). When stratified by procedure, this effect was observed only following MSA. Patients with BMI ≥35 kg/m² undergoing MSA had higher postoperative DeMeester scores [28.7 (36.3) vs. 14.5 (20.6), P=0.001] and lower rates of acid normalization (48.1% vs. 71.0%, P=0.002). In contrast, postoperative DeMeester scores (P=0.322) and rates of acid normalization (P=0.900) were similar across BMI groups following fundoplication. Further stratification by BMI showed that higher BMI was associated with lower rates of pH normalization following MSA (P=0.002), whereas pH normalization remained consistent across BMI categories after fundoplication (P=0.677) (Fig. 1). One-year distal esophageal acid normalization following primary ARS, stratified by BMI subgroups. A, Fundoplication: pH normalization rates were similar across all BMI subgroups. B, MSA: patients with BMI ≥35 kg/m² had significantly lower rates of pH normalization compared with other BMI subgroups. C, In patients with BMI ≥35 kg/m², those who underwent MSA had a significantly lower rate of pH normalization than those who underwent fundoplication. Probability of Postoperative pH Normalization as a Function of BMI The predicted probability of pH normalization after fundoplication and MSA by BMI from 30.0 to 39.9 kg/m2 is shown in Figure 2. For patients undergoing fundoplication, the probability of pH normalization remained stable at approximately 0.75, independent of BMI. For patients undergoing MSA, the probability of pH normalization declined with increasing BMI. Predicted probability of pH normalization by BMI from 30.0 to 39.9 kg/m2, for (A) fundoplication and (B) MSA. Shaded areas indicate 95% confidence interval associated with the predicted probability at each BMI value. For patients undergoing MSA, the predicted probability of pH normalization declined with increasing BMI, while for fundoplication patients the probability of pH normalization remained stable at around 0.75 independent of BMI. Exploratory cut-point analyses (BMI 30–39 kg/m²) were performed to identify the threshold at which pH normalization most clearly diverged between BMI groups. A threshold at 35 kg/m² was identified following MSA, with BMI <35 kg/m² associated with highest odds of normalization (OR 2.6, 95% CI: 1.5–4.7; P=0.001). No discriminative BMI threshold was observed for fundoplication. Impact of Obesity on Anatomic Failure and Revisional Surgery Anatomic failure and revisional surgery rates were similar between BMI groups. Anatomic failure occurred in 6.6% of patients with BMI ≥35 kg/m² and 6.8% with BMI <35 kg/m² at 1 year (P=0.913) and occurred in 24.2% and 21.8% of patients at 5 years, respectively (P=0.469). Revisional surgery rates were also similar over 5 years (4.5% vs. 5.3%, P=0.574). Findings were consistent across MSA and fundoplication (Fig. 3). Long-term durability following primary ARS, stratified by body mass index (BMI <35 vs. ≥35 kg/m²) and procedure. (A) One-year and (B) 5-year anatomic failure rates were comparable between BMI groups. No differences were observed in (C) 1-year and (D) 5-year rates of revisional surgery between BMI groups. Cox proportional hazards models demonstrated no significant differences in mean time to anatomic failure within 5 years between BMI groups in the overall cohort (4.2 vs. 4.1 years, P=0.446). Similarly, mean time to revisional surgery did not differ between BMI groups (4.8 vs. 4.7 years, P=0.195). Mean time to anatomic failure and mean time to revision were also similar between BMI groups when stratified by procedure (Fig. 4). Time-to-event outcomes following primary ARS, stratified by body mass index (BMI <35 vs. ≥35 kg/m²). (A) Total population time to anatomic failure was similar between BMI groups. Similarly, there were no differences in time to anatomic failure after (B) fundoplication or (C) MSA between BMI groups. Time to revisional surgery was similar between BMI groups in the (D) total population, and after (E) fundoplication and (F) MSA. Impact of BMI Across Clinical and Demographic Subgroups In subgroup analyses stratified by sex, age, and hernia size, rates of anatomic failure and revisional surgery remained comparable between BMI groups at 1 and 5 years (all P>0.05). Similarly, pH normalization did not differ by BMI across subgroups among patients undergoing fundoplication (all P>0.05). In contrast, among patients undergoing MSA, higher BMI (≥35 kg/m²) was associated with lower rates of pH normalization in both male and female patients and in those with larger hernias (all P<0.05). In age-stratified analyses, lower rates of pH normalization were observed in patients aged ≥60 years with BMI ≥35 kg/m² (P=0.008) (Supplemental Table 2, Supplemental Digital Content 1, http://links.lww.com/SLA/F847). Impact of Fundoplication Type on Outcomes Of the 1641 patients undergoing primary fundoplication, 1383 (84.3%) underwent Nissen fundoplication, with the remainder receiving a partial fundoplication. Symptom scores, freedom from proton pump inhibitors, and patient satisfaction were comparable between BMI groups across both fundoplication types (all P>0.05). Rates of anatomic failure and revisional surgery at 1 and 5 years were likewise similar between BMI groups within each fundoplication subtype (all P>0.05). Time-to-event analyses demonstrated no differences in time to anatomic failure or revisional surgery between BMI groups within either fundoplication subtype (all P>0.05). Analyses Across Higher BMI Thresholds Analyses using higher BMI thresholds (36–39 kg/m²), reflecting incremental cutoffs within class II obesity, yielded findings consistent with the primary analysis using a cutoff of 35 kg/m². Symptomatic outcomes, objective reflux control, and durability remained comparable across BMI groups at all thresholds. Reduced pH normalization following MSA persisted across higher BMI thresholds, whereas no differences were observed following fundoplication. DISCUSSION Obesity has a well-established relationship with reflux disease; however, its impact on the outcomes of ARS remains uncertain.2,3 Increased visceral adiposity is associated with an elevated thoracoabdominal pressure gradient, which augments axial stress at the esophageal hiatus and promotes gastroesophageal reflux and hiatal hernia formation.21 Prior studies evaluating outcomes after ARS in obese patients have been limited by heterogeneity in outcome definitions, inconsistent use of objective physiologic measures, and use of a threshold BMI of 30 kg/m2.7,10,11 Given the increasing prevalence of obesity, a BMI threshold of ≥35 kg/m2 may better reflect the contemporary surgical population and provide a more clinically relevant cutoff for outcome assessment. In this study, patients with BMI ≥35 kg/m2 demonstrated more severe symptoms and greater esophageal acid exposure preoperatively, consistent with the established relationship between obesity and reflux disease. Despite this, obesity was not associated with worse clinical outcomes after ARS. Symptom relief, patient satisfaction, freedom from PPI use, and structural durability were comparable between obese and nonobese patients, and these findings persisted after adjustment for baseline characteristics and disease severity. These findings were consistent following fundoplication, where rates of pH normalization were similar across BMI strata. In contrast, patients undergoing MSA demonstrated lower rates of postoperative pH normalization with increasing BMI. However, this difference in objective reflux control did not translate into inferior symptom outcomes. Early retrospective reports suggested that obesity adversely affects symptomatic reflux control after ARS.4,7 However, subsequent studies have not consistently reproduced this finding. Multiple institutional cohorts have demonstrated comparable postoperative clinical outcomes across BMI groups, including heartburn relief, regurgitation control, patient satisfaction, and GERD-specific quality of life.9,11,15,22–26 A recent large cohort study demonstrated equivalent postoperative GERD-HRQL scores and satisfaction rates across BMI categories, including class II–III obesity.17 These findings are consistent with our results and support the observation that BMI alone may not adversely affect clinical outcomes after ARS. Despite having larger hiatal hernias, patients with BMI ≥35 had comparable rates of anatomic failure and revisional surgery to those with BMI <35. While early studies reported hiatal hernia recurrence rates up to 31% in this population, contemporary series match our results.7 In single-center cohorts, BMI was not associated with differences in hiatal hernia recurrence or revisional surgery.17,27 A recent propensity-matched study demonstrated no difference in 5-year hernia recurrence across a BMI threshold of 35 kg/m2, while revisional cohorts report conflicting results regarding the impact of BMI on hiatal hernia recurrence.18,28,29 Despite the physiologic rationale that increased intra-abdominal pressure may predispose to anatomic failure, these findings and our results suggest that BMI may not independently predict structural durability or the need for reoperation after ARS. In the present study, the relationship between BMI and objective pH normalization after ARS differed by procedure. Following fundoplication, pH normalization was consistent across BMI strata, while BMI ≥35 was associated with lower rates of pH normalization following MSA. These findings align with prior series demonstrating BMI-independent pH normalization after fundoplication.17 A revisional fundoplication cohort similarly demonstrated no association between BMI and postoperative DeMeester score.29 By comparison, the relationship between BMI and pH normalization after MSA remains less well defined. In a large contemporary multicenter series of patients undergoing MSA, preoperative DeMeester scores increased with BMI while postoperative scores did not differ across BMI categories, though the limited number of patients with class II–III obesity and postoperative pH testing precluded a robust evaluation of postoperative pH normalization.16 In aggregate, these findings and our results suggest a procedure-specific association between BMI and pH normalization. The divergence in the relationship between BMI and pH normalization after MSA and fundoplication despite comparable anatomic durability rates may reflect fundamental biomechanical differences between these reflux barrier reconstructions. Fundoplication increases gastric yield pressure to approximately 40 mmHg through a compliant repair that generates progressively greater elastic resistance with increasing distention.30,31 In contrast, MSA yields at approximately 30 mmHg, a threshold determined by magnetic attractive force that diminishes exponentially as the device separates.32,33 The increased intra-abdominal pressure from visceral obesity narrows the physiologic reserve between gastric pressure and the MSA yield pressure.2 As intragastric pressure approaches this lower yield threshold, barrier competence is challenged and normalization of distal acid exposure becomes less likely even with preserved anatomy. Exploratory analyses demonstrated a progressive decline in pH normalization with increasing BMI following MSA, with a BMI of 35 representing the most discriminative threshold. In contrast, no such relationship was observed after fundoplication. Higher BMI was not associated with worse postoperative outcomes across fundoplication subtypes. Symptom control, freedom from PPI use, and patient satisfaction were comparable between BMI groups for both Nissen and partial fundoplication. Similarly, rates of anatomic failure, revisional surgery, and time to failure were not influenced by BMI within either fundoplication subtype, suggesting that increased BMI does not adversely impact the durability of fundoplication. These findings are notable given that the choice of fundoplication technique is often influenced by baseline disease severity, esophageal motility, and surgeon preference. Despite these differences in patient selection, outcomes remained consistent across BMI strata within each subtype. Prior studies examining outcomes by fundoplication technique in obese patients are limited. In a 684-patient cohort, higher rates of recurrent reflux were observed in obese patients after both Toupet and Nissen fundoplication, although direct comparisons between techniques were not performed.34 This study has several methodological strengths. It includes a large cohort with structured postoperative physiologic and endoscopic follow-up, allowing assessment of objective outcomes such as pH normalization, anatomic durability, and revisional surgery rather than relying solely on symptom reporting. Outcomes were analyzed separately for fundoplication and MSA, acknowledging the distinct biomechanical properties of these reconstructions. BMI was evaluated across multiple thresholds within class II obesity to assess the robustness of its association with objective outcomes. These findings, however, should be interpreted in the context of several limitations. The retrospective design introduces potential selection bias and residual confounding despite adjusted analyses. The experience of a high-volume foregut center with structured postoperative testing may limit generalizability. The number of patients with class III obesity (BMI ≥40 kg/m²) was limited, restricting meaningful evaluation within this subgroup. Although exploratory analyses within class II obesity suggested similar directional trends at higher BMI thresholds, the present findings should not be extrapolated to patients with BMI ≥40 kg/m² given the limited representation of these patients in the current cohort. In addition, gastric emptying studies were not routinely performed in all patients, limiting the ability to fully evaluate the contribution of delayed gastric emptying to postoperative reflux physiology. Prospective evaluation in cohorts with greater representation of patients with severe obesity and more comprehensive assessment of foregut motility and gastric emptying is warranted. The findings of the present study have implications in the broader context of managing GERD in patients with obesity. Roux-en-Y gastric bypass provides well-established metabolic and reflux-protective benefits and remains an effective option for selected patients with severe obesity; however, its role in reflux control must be considered alongside other treatment strategies.35,36 National utilization patterns have shifted over recent years, with declining use of Roux-en-Y gastric bypass and increasing adoption of sleeve gastrectomy, which is recognized to be refluxogenic.37–39 In parallel, the expanding use of glucagon-like peptide-1 receptor agonists for weight loss does not directly address reflux and, in some formulations, has been associated with increased risk of GERD and esophagitis.40 Recent multisociety consensus statements emphasize individualized decision-making when selecting between bariatric procedures and ARS in patients with obesity and GERD, acknowledging limited comparative data and variable reflux outcomes after bypass.19,20 In this context, our findings support ARS as an effective option for reflux control in appropriately selected patients with obesity. CONCLUSION In this large cohort of patients undergoing primary ARS, obesity was not associated with diminished symptomatic benefits or long-term anatomic durability. Despite more advanced preoperative disease, obese patients achieved equivalent symptom relief, satisfaction, freedom from proton pump inhibitor use, and freedom from revisional surgery compared with nonobese patients. Objective reflux control after fundoplication remained stable across BMI strata, with preserved pH normalization and no increase in anatomic recurrence or reoperation. In contrast, MSA was associated with reduced pH normalization at higher BMI levels, without corresponding differences in symptom control, structural failure, or need for reintervention. These findings suggest that class II obesity does not independently predict inferior symptomatic or structural outcomes after ARS, although the relationship between BMI and postoperative pH normalization appears to be procedure-specific. Supplementary Material